Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Daffé M[au]:

Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane. Chiaradia L et al. Sci Rep. (2017)

Mycolic acids: structures, biosynthesis, and beyond. Marrakchi H et al. Chem Biol. (2014)

AhR sensing of bacterial pigments regulates antibacterial defence. Moura-Alves P et al. Nature. (2014)

Search results

Items: 1 to 50 of 242

1.

Unraveling the Structure of the Mycobacterial Envelope.

Daffé M, Marrakchi H.

Microbiol Spectr. 2019 Jul;7(4). doi: 10.1128/microbiolspec.GPP3-0027-2018.

PMID:
31267927
2.

Cpn60.1 (GroEL1) Contributes to Mycobacterial Crabtree Effect: Implications for Biofilm Formation.

Zeng S, Constant P, Yang D, Baulard A, Lefèvre P, Daffé M, Wattiez R, Fontaine V.

Front Microbiol. 2019 Jun 11;10:1149. doi: 10.3389/fmicb.2019.01149. eCollection 2019.

3.

Impact of Tetracationic Calix[4]arene Conformation-from Conic Structure to Expanded Bolaform-on Their Antibacterial and Antimycobacterial Activities.

Mourer M, Duval RE, Constant P, Daffé M, Regnouf-de-Vains JB.

Chembiochem. 2019 Apr 1;20(7):911-921. doi: 10.1002/cbic.201800609. Epub 2019 Mar 4.

PMID:
30512240
4.

Correction: Implications of the Ebola virus disease outbreak in Guinea: Qualitative findings to inform future health and nutrition-related responses.

Kodish SR, Rohner F, Beauliere JM, Daffe M, Ayoya MA, Wirth JP, Ngnie-Teta I.

PLoS One. 2018 Oct 3;13(10):e0204675. doi: 10.1371/journal.pone.0204675. eCollection 2018.

5.

Implications of the Ebola virus disease outbreak in Guinea: Qualitative findings to inform future health and nutrition-related responses.

Kodish SR, Rohner F, Beauliere JM, Daffe M, Ayoya MA, Wirth JP, Ngnie-Teta I.

PLoS One. 2018 Aug 23;13(8):e0202468. doi: 10.1371/journal.pone.0202468. eCollection 2018. Erratum in: PLoS One. 2018 Oct 3;13(10):e0204675.

6.

Aloe Emodin Reduces Phthiodiolone Dimycocerosate Potentiating Vancomycin Susceptibility on Mycobacteria.

Rens C, Ceyssens PJ, Laval F, Lefèvre P, Mathys V, Daffé M, Fontaine V.

Indian J Microbiol. 2018 Sep;58(3):393-396. doi: 10.1007/s12088-018-0734-0. Epub 2018 May 4.

PMID:
30013284
7.

HadD, a novel fatty acid synthase type II protein, is essential for alpha- and epoxy-mycolic acid biosynthesis and mycobacterial fitness.

Lefebvre C, Boulon R, Ducoux M, Gavalda S, Laval F, Jamet S, Eynard N, Lemassu A, Cam K, Bousquet MP, Bardou F, Burlet-Schiltz O, Daffé M, Quémard A.

Sci Rep. 2018 Apr 16;8(1):6034. doi: 10.1038/s41598-018-24380-5.

8.

I3-Ag85 effect on phthiodiolone dimycocerosate synthesis.

Rens C, Laval F, Wattiez R, Lefèvre P, Dufrasne F, Daffé M, Fontaine V.

Tuberculosis (Edinb). 2018 Jan;108:93-95. doi: 10.1016/j.tube.2017.10.007. Epub 2017 Oct 24.

PMID:
29523333
9.

Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria.

Madacki J, Laval F, Grzegorzewicz A, Lemassu A, Záhorszká M, Arand M, McNeil M, Daffé M, Jackson M, Lanéelle MA, Korduláková J.

J Biol Chem. 2018 Apr 6;293(14):5172-5184. doi: 10.1074/jbc.RA117.000246. Epub 2018 Feb 22.

10.

Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane.

Chiaradia L, Lefebvre C, Parra J, Marcoux J, Burlet-Schiltz O, Etienne G, Tropis M, Daffé M.

Sci Rep. 2017 Oct 9;7(1):12807. doi: 10.1038/s41598-017-12718-4.

11.

Surgical Treatment of Angular Pott's Kyphosis with Posterior Approach, Pedicular Wedge Osteotomy and Canal Widening.

Kinkpe CV, Onimus M, Sarr L, Niane MM, Traore MM, Daffe M, Gueye AB.

Open Orthop J. 2017 Mar 31;11:274-280. doi: 10.2174/1874325001711010274. eCollection 2017.

12.

Cell wall peptidolipids of Mycobacterium avium: from genetic prediction to exact structure of a nonribosomal peptide.

Bannantine JP, Etienne G, Laval F, Stabel JR, Lemassu A, Daffé M, Bayles DO, Ganneau C, Bonhomme F, Branger M, Cochard T, Bay S, Biet F.

Mol Microbiol. 2017 Aug;105(4):525-539. doi: 10.1111/mmi.13717. Epub 2017 Jun 15.

13.

Identification of specific posttranslational O-mycoloylations mediating protein targeting to the mycomembrane.

Carel C, Marcoux J, Réat V, Parra J, Latgé G, Laval F, Demange P, Burlet-Schiltz O, Milon A, Daffé M, Tropis MG, Renault MAM.

Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4231-4236. doi: 10.1073/pnas.1617888114. Epub 2017 Apr 3.

14.

Elionurus tristis Essential Oil: GC-MS Analysis and Antioxidant and Antituberculosis Activities.

Yedomon BH, Saves I, Mtimet N, Raoelison EG, Constant P, Daffé M, Bouajila J.

Nat Prod Commun. 2017 Apr;12(4):615-618.

PMID:
30520608
15.

[Early form of Wilkie's syndrome: a rare complication of scoliosis surgery, about a case and review of the literature].

Traore MM, Leye PA, Bah MD, Kinkpe CV, Ndiaye PI, Daffe M, Toure AO, Kane O.

Pan Afr Med J. 2016 Oct 17;25:90. doi: 10.11604/pamj.2016.25.90.8773. eCollection 2016. Review. French.

16.

Click-chemistry approach to study mycoloylated proteins: Evidence for PorB and PorC porins mycoloylation in Corynebacterium glutamicum.

Issa H, Huc-Claustre E, Reddad T, Bonadé Bottino N, Tropis M, Houssin C, Daffé M, Bayan N, Dautin N.

PLoS One. 2017 Feb 15;12(2):e0171955. doi: 10.1371/journal.pone.0171955. eCollection 2017.

17.

Ser/Thr Phosphorylation Regulates the Fatty Acyl-AMP Ligase Activity of FadD32, an Essential Enzyme in Mycolic Acid Biosynthesis.

Le NH, Molle V, Eynard N, Miras M, Stella A, Bardou F, Galandrin S, Guillet V, André-Leroux G, Bellinzoni M, Alzari P, Mourey L, Burlet-Schiltz O, Daffé M, Marrakchi H.

J Biol Chem. 2016 Oct 21;291(43):22793-22805. Epub 2016 Sep 2.

18.

pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence.

Boritsch EC, Frigui W, Cascioferro A, Malaga W, Etienne G, Laval F, Pawlik A, Le Chevalier F, Orgeur M, Ma L, Bouchier C, Stinear TP, Supply P, Majlessi L, Daffé M, Guilhot C, Brosch R.

Nat Microbiol. 2016 Jan 27;1:15019. doi: 10.1038/nmicrobiol.2015.19.

PMID:
27571976
19.

Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria.

Rens C, Laval F, Daffé M, Denis O, Frita R, Baulard A, Wattiez R, Lefèvre P, Fontaine V.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6193-9. doi: 10.1128/AAC.00872-16. Print 2016 Oct.

20.

Trehalose Polyphleates Are Produced by a Glycolipid Biosynthetic Pathway Conserved across Phylogenetically Distant Mycobacteria.

Burbaud S, Laval F, Lemassu A, Daffé M, Guilhot C, Chalut C.

Cell Chem Biol. 2016 Feb 18;23(2):278-289. doi: 10.1016/j.chembiol.2015.11.013. Epub 2016 Jan 28.

21.

Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria.

Guillet V, Galandrin S, Maveyraud L, Ladevèze S, Mariaule V, Bon C, Eynard N, Daffé M, Marrakchi H, Mourey L.

J Biol Chem. 2016 Apr 8;291(15):7973-89. doi: 10.1074/jbc.M115.712612. Epub 2016 Feb 21.

22.

Modified Dunn osteotomy using an anterior approach used to treat 26 cases of SCFE.

Niane MM, Kinkpé CV, Daffé M, Sarr L, Gueye AB, Sané AD, Séye SI.

Orthop Traumatol Surg Res. 2016 Feb;102(1):81-5. doi: 10.1016/j.otsr.2015.10.005. Epub 2015 Dec 22.

23.

The Non-Essential Mycolic Acid Biosynthesis Genes hadA and hadC Contribute to the Physiology and Fitness of Mycobacterium smegmatis.

Jamet S, Slama N, Domingues J, Laval F, Texier P, Eynard N, Quémard A, Peixoto A, Lemassu A, Daffé M, Cam K.

PLoS One. 2015 Dec 23;10(12):e0145883. doi: 10.1371/journal.pone.0145883. eCollection 2015.

24.

The changes in mycolic acid structures caused by hadC mutation have a dramatic effect on the virulence of Mycobacterium tuberculosis.

Slama N, Jamet S, Frigui W, Pawlik A, Bottai D, Laval F, Constant P, Lemassu A, Cam K, Daffé M, Brosch R, Eynard N, Quémard A.

Mol Microbiol. 2016 Feb;99(4):794-807. doi: 10.1111/mmi.13266. Epub 2015 Nov 27.

25.

Evolution of Mycolic Acid Biosynthesis Genes and Their Regulation during Starvation in Mycobacterium tuberculosis.

Jamet S, Quentin Y, Coudray C, Texier P, Laval F, Daffé M, Fichant G, Cam K.

J Bacteriol. 2015 Dec;197(24):3797-811. doi: 10.1128/JB.00433-15. Epub 2015 Sep 28.

26.

Guanidinium compounds with sub-micromolar activities against Mycobacterium tuberculosis. Synthesis, characterization and biological evaluations.

Massimba-Dibama H, Mourer M, Constant P, Daffé M, Regnouf-de-Vains JB.

Bioorg Med Chem. 2015 Sep 1;23(17):5410-8. doi: 10.1016/j.bmc.2015.07.053. Epub 2015 Jul 29.

PMID:
26254828
27.

Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids.

Daffé M, Crick DC, Jackson M.

Microbiol Spectr. 2014 Aug;2(4):MGM2-0021-2013. doi: 10.1128/microbiolspec.MGM2-0021-2013. Review.

PMID:
26104202
28.

Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria.

Soetaert K, Rens C, Wang XM, De Bruyn J, Lanéelle MA, Laval F, Lemassu A, Daffé M, Bifani P, Fontaine V, Lefèvre P.

Antimicrob Agents Chemother. 2015 Aug;59(8):5057-60. doi: 10.1128/AAC.04856-14. Epub 2015 Jun 1.

29.

The Cyclic Di-GMP Phosphodiesterase Gene Rv1357c/BCG1419c Affects BCG Pellicle Production and In Vivo Maintenance.

Flores-Valdez MA, Aceves-Sánchez Mde J, Pedroza-Roldán C, Vega-Domínguez PJ, Prado-Montes de Oca E, Bravo-Madrigal J, Laval F, Daffé M, Koestler B, Waters CM.

IUBMB Life. 2015 Feb;67(2):129-38. doi: 10.1002/iub.1353. Epub 2015 Apr 11.

30.

The cell envelope of tubercle bacilli.

Daffé M.

Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S155-8. doi: 10.1016/j.tube.2015.02.024. Epub 2015 Mar 13.

PMID:
25819158
31.

Lipid and lipoarabinomannan isolation and characterization.

Lanéelle MA, Nigou J, Daffé M.

Methods Mol Biol. 2015;1285:77-103. doi: 10.1007/978-1-4939-2450-9_5.

PMID:
25779311
32.

Characterization of the mycobacterial acyl-CoA carboxylase holo complexes reveals their functional expansion into amino acid catabolism.

Ehebauer MT, Zimmermann M, Jakobi AJ, Noens EE, Laubitz D, Cichocki B, Marrakchi H, Lanéelle MA, Daffé M, Sachse C, Dziembowski A, Sauer U, Wilmanns M.

PLoS Pathog. 2015 Feb 19;11(2):e1004623. doi: 10.1371/journal.ppat.1004623. eCollection 2015 Feb.

33.

Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids.

Daffé M, Crick DC, Jackson M.

Microbiol Spectr. 2014;2(4). pii: 14.

34.

The polyketide synthase Pks13 catalyzes a novel mechanism of lipid transfer in mycobacteria.

Gavalda S, Bardou F, Laval F, Bon C, Malaga W, Chalut C, Guilhot C, Mourey L, Daffé M, Quémard A.

Chem Biol. 2014 Dec 18;21(12):1660-9. doi: 10.1016/j.chembiol.2014.10.011. Epub 2014 Nov 26.

35.

AhR sensing of bacterial pigments regulates antibacterial defence.

Moura-Alves P, Faé K, Houthuys E, Dorhoi A, Kreuchwig A, Furkert J, Barison N, Diehl A, Munder A, Constant P, Skrahina T, Guhlich-Bornhof U, Klemm M, Koehler AB, Bandermann S, Goosmann C, Mollenkopf HJ, Hurwitz R, Brinkmann V, Fillatreau S, Daffe M, Tümmler B, Kolbe M, Oschkinat H, Krause G, Kaufmann SH.

Nature. 2014 Aug 28;512(7515):387-92. doi: 10.1038/nature13684. Epub 2014 Aug 13.

PMID:
25119038
36.

Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator.

Gonzalo-Asensio J, Malaga W, Pawlik A, Astarie-Dequeker C, Passemar C, Moreau F, Laval F, Daffé M, Martin C, Brosch R, Guilhot C.

Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11491-6. doi: 10.1073/pnas.1406693111. Epub 2014 Jul 21.

37.

Mycobacterium tuberculosis proteins involved in mycolic acid synthesis and transport localize dynamically to the old growing pole and septum.

Carel C, Nukdee K, Cantaloube S, Bonne M, Diagne CT, Laval F, Daffé M, Zerbib D.

PLoS One. 2014 May 9;9(5):e97148. doi: 10.1371/journal.pone.0097148. eCollection 2014.

38.

Mycolic acids: structures, biosynthesis, and beyond.

Marrakchi H, Lanéelle MA, Daffé M.

Chem Biol. 2014 Jan 16;21(1):67-85. doi: 10.1016/j.chembiol.2013.11.011. Epub 2013 Dec 26. Review.

39.

M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.

Hedhli D, Denis O, Barkan D, Daffé M, Glickman MS, Huygen K.

PLoS One. 2013 Oct 17;8(10):e76442. doi: 10.1371/journal.pone.0076442. eCollection 2013.

40.

Current knowledge on mycolic acids in Corynebacterium glutamicum and their relevance for biotechnological processes.

Lanéelle MA, Tropis M, Daffé M.

Appl Microbiol Biotechnol. 2013 Dec;97(23):9923-30. doi: 10.1007/s00253-013-5265-3. Epub 2013 Oct 11. Review.

PMID:
24113823
41.

NMR localization of the O-mycoloylation on PorH, a channel forming peptide from Corynebacterium glutamicum.

Rath P, Saurel O, Tropis M, Daffé M, Demange P, Milon A.

FEBS Lett. 2013 Nov 15;587(22):3687-91. doi: 10.1016/j.febslet.2013.09.032. Epub 2013 Oct 4.

42.

Identification of a mycoloyl transferase selectively involved in O-acylation of polypeptides in Corynebacteriales.

Huc E, de Sousa-D'Auria C, de la Sierra-Gallay IL, Salmeron C, van Tilbeurgh H, Bayan N, Houssin C, Daffé M, Tropis M.

J Bacteriol. 2013 Sep;195(18):4121-8. doi: 10.1128/JB.00285-13. Epub 2013 Jul 12.

43.

Cord factor (trehalose 6,6'-dimycolate) forms fully stable and non-permeable lipid bilayers required for a functional outer membrane.

Rath P, Saurel O, Czaplicki G, Tropis M, Daffé M, Ghazi A, Demange P, Milon A.

Biochim Biophys Acta. 2013 Sep;1828(9):2173-81. doi: 10.1016/j.bbamem.2013.04.021. Epub 2013 May 1.

44.

Functional characterisation of three o-methyltransferases involved in the biosynthesis of phenolglycolipids in Mycobacterium tuberculosis.

Simeone R, Huet G, Constant P, Malaga W, Lemassu A, Laval F, Daffé M, Guilhot C, Chalut C.

PLoS One. 2013;8(3):e58954. doi: 10.1371/journal.pone.0058954. Epub 2013 Mar 11.

45.

Assay development for identifying inhibitors of the mycobacterial FadD32 activity.

Galandrin S, Guillet V, Rane RS, Léger M, N R, Eynard N, Das K, Balganesh TS, Mourey L, Daffé M, Marrakchi H.

J Biomol Screen. 2013 Jun;18(5):576-87. doi: 10.1177/1087057112474691. Epub 2013 Jan 30.

PMID:
23364516
46.

Structural elucidation and genomic scrutiny of the C60-C100 mycolic acids of Segniliparus rotundus.

Lanéelle MA, Eynard N, Spina L, Lemassu A, Laval F, Huc E, Etienne G, Marrakchi H, Daffé M.

Microbiology. 2013 Jan;159(Pt 1):191-203. doi: 10.1099/mic.0.063479-0. Epub 2012 Nov 15.

PMID:
23154972
47.

A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone.

Grzegorzewicz AE, Korduláková J, Jones V, Born SE, Belardinelli JM, Vaquié A, Gundi VA, Madacki J, Slama N, Laval F, Vaubourgeix J, Crew RM, Gicquel B, Daffé M, Morbidoni HR, Brennan PJ, Quémard A, McNeil MR, Jackson M.

J Biol Chem. 2012 Nov 9;287(46):38434-41. doi: 10.1074/jbc.M112.400994. Epub 2012 Sep 21.

48.

Antibacterial, antifungal and antileishmanial activities of indolone-N-oxide derivatives.

Ibrahim H, Furiga A, Najahi E, Pigasse Hénocq C, Nallet JP, Roques C, Aubouy A, Sauvain M, Constant P, Daffé M, Nepveu F.

J Antibiot (Tokyo). 2012 Oct;65(10):499-504. doi: 10.1038/ja.2012.60. Epub 2012 Jul 25.

PMID:
22828966
49.

Biochemical and structural study of the atypical acyltransferase domain from the mycobacterial polyketide synthase Pks13.

Bergeret F, Gavalda S, Chalut C, Malaga W, Quémard A, Pedelacq JD, Daffé M, Guilhot C, Mourey L, Bon C.

J Biol Chem. 2012 Sep 28;287(40):33675-90. Epub 2012 Jul 23.

50.

Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives.

Mourer M, Massimba Dibama H, Constant P, Daffé M, Regnouf-de-Vains JB.

Bioorg Med Chem. 2012 Mar 15;20(6):2035-41. doi: 10.1016/j.bmc.2012.01.041. Epub 2012 Feb 2.

PMID:
22361273

Supplemental Content

Support Center